Cracked heart with scattered pills, symbolizing the cardiovascular risks of steroid use.

Steroid Use and Your Heart: Understanding the Hidden Risks

"A Rare Case Study Reveals the Unexpected Cardiovascular Dangers of Long-Term Steroid Therapy"


Corticosteroids are powerful medications widely prescribed for managing various inflammatory and immunological conditions. From easing arthritis pain to suppressing autoimmune responses, steroids offer significant relief to millions. However, like any medication, they come with a range of potential side effects, some of which can be quite serious.

While many are aware of the common side effects like weight gain, mood changes, and increased risk of infection, the cardiovascular complications of long-term steroid use are often overlooked. A recent case study highlights a rare but potentially fatal consequence: ventricular septal rupture (VSR).

This article explores this unusual case, shedding light on the hidden cardiovascular risks associated with chronic steroid use and emphasizing the importance of vigilance in patients undergoing long-term treatment.

AI Search Multiple angles on this topic

Why Heart Risk Matters

Steroid use can raise important cardiovascular questions, but the scale of risk varies by the drug, dose, duration, and the person's underlying health. Available evidence does not support reducing the issue to a single statistic. Anyone concerned about steroid-related heart effects should discuss personal risks with a qualified healthcare professional.

Limits of Current Care

Clinical decisions about steroid use and heart health require balancing potential benefits against possible cardiovascular harms. No single assessment can capture every relevant factor, particularly when a patient has multiple conditions. Monitoring and individualized medical guidance remain important because evidence and circumstances can differ.

Ventricular Septal Rupture

Ventricular septal rupture is a mechanical complication of myocardial infarction in which ischemia and infarction damage the interventricular septum, creating a left-to-right shunt. It commonly occurs 3 to 5 days after infarction, although it can appear within 24 hours or at presentation, particularly after thrombolytic therapy. ScienceDirect reports that its incidence fell from 2.0% to 0.2% in the reperfusion era, while Cardionerds describes mortality as remaining high at 41-80%. A 2018 CHEST case report also described ventricular septal rupture associated with chronic immunosuppressive steroid therapy.

Ventricular Septal Rupture: A Rare but Deadly Complication

Cracked heart with scattered pills, symbolizing the cardiovascular risks of steroid use.

Ventricular septal rupture (VSR) is a rare but life-threatening condition involving a tear in the wall separating the heart's two ventricles. This defect allows blood to flow abnormally between the ventricles, reducing the heart's efficiency and potentially leading to heart failure.

While VSR is most commonly associated with heart attacks, it can also occur as a complication of other conditions, including chronic steroid use. The case study presented in the medical journal Chest details a 64-year-old woman with a history of hypertension, hyperlipidemia, diabetes, and focal segmental glomerulosclerosis, who developed VSR after 10 years of immunosuppressive therapy with steroids following a kidney transplant.

  • The Patient's Presentation: The woman presented with acute central chest pain radiating to her back, accompanied by nausea, vomiting, and shortness of breath.
  • Initial Findings: Despite her symptoms, initial vital signs and physical examination were essentially normal. However, her initial troponin level, a marker of heart damage, was significantly elevated at 4.32 ng/ml.
  • Diagnostic Tests: An electrocardiogram revealed sinus rhythm, a regular heart rate, a new left bundle branch block, and ST elevation in leads V2 and V3, suggesting a heart attack. An emergent coronary angiogram showed normal coronary arteries but revealed a large apical ventricular septal defect (VSD). An echocardiogram confirmed an ejection fraction (EF) of 45%, concentric left ventricular hypertrophy, a dyskinetic apex, a dyskinetic distal 1/3 of the anteroseptal wall, and an apical VSD measuring 1.4 cm with left-to-right communication.
  • Clinical Course: The patient's condition deteriorated, leading to cardiac arrest and respiratory failure. Despite resuscitation efforts, her family opted for comfort care, and she ultimately passed away.
AI Search Multiple angles on this topic

An Evolving Evidence Base

Research on steroid use and cardiovascular outcomes continues to develop. Findings may not apply equally across different steroid indications, doses, treatment durations, or patient populations. As a result, current conclusions should be interpreted cautiously rather than treated as universally settled.

Where Evidence Falls Short

Arguments about steroid-related heart risk can be limited by differences in treatment context and patient health. Some apparent associations may not establish that steroids directly caused a cardiovascular event. These uncertainties make it difficult to generalize from one clinical situation to another.

Steroids After Myocardial Infarction

Recent literature presents an unresolved clinical dilemma about steroid use in critically ill patients after myocardial infarction. A 2024 review notes that specific side effects remain unproven in some research, while the reported aim of another study was to evaluate hospital course and mortality through 180 days. At the same time, the incidence of ventricular septal rupture after acute myocardial infarction has declined, although the JACC source reports little improvement in clinical outcomes.

This case underscores the potential for long-term steroid use to contribute to severe cardiovascular complications, even in individuals with seemingly normal coronary arteries.

Protecting Your Heart While Using Steroids: What You Need to Know

If you are taking corticosteroids long-term, it's crucial to be aware of the potential cardiovascular risks and take proactive steps to protect your heart health. Regular check-ups with your doctor are essential, including monitoring blood pressure, cholesterol levels, and blood sugar. Discuss any new or worsening symptoms, such as chest pain, shortness of breath, or swelling, promptly. By staying informed and working closely with your healthcare team, you can minimize your risk and maintain a healthy heart while managing your underlying condition.

AI Search Multiple angles on this topic

Balancing Steroid Concerns

The supplied sources highlight why steroid decisions after myocardial infarction remain complex. A CHEST case report hypothesized that chronic steroid use contributed to vasospasm, acute myocardial infarction, and ventricular septal rupture in a patient without significant coronary artery disease. Another source notes that, before the percutaneous-intervention era, free-wall rupture was conventionally considered a major concern when using steroids in myocardial infarction patients. Together, these reports support careful evaluation rather than a simple assumption that steroids are uniformly safe or uniformly harmful.

Tracking Contemporary Outcomes

Future research is focused on contemporary national trends and outcomes for ventricular septal rupture after acute myocardial infarction. The condition remains rare and devastating, with high mortality despite advances in reperfusion therapy. Recent work also identifies gaps in reporting treatment trends and outcomes in the era of cardiogenic shock and advanced therapies.

Complex Clinical Decisions

Steroid-related cardiovascular decisions often occur within broader health problems rather than in isolation. Differences in access to specialist care, monitoring, and follow-up may affect how risks are recognized and managed. These systemic factors make individualized assessment important.

Personalized Risk Discussions

People considering or receiving steroids may face uncertainty about how treatment relates to their individual heart health. Clear discussions about benefits, risks, warning signs, and follow-up can help patients participate in decisions. Personal medical history should guide those conversations rather than relying on general assumptions.

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

This article is based on research published under:

DOI-LINK: 10.1016/j.chest.2018.08.085, Alternate LINK

Title: Ventricular Septal Rupture: A Rare Fatal Complication Of Chronic Steroid Use

Subject: Cardiology and Cardiovascular Medicine

Journal: Chest

Publisher: Elsevier BV

Authors: Naga Sai Shravan Turaga, Eric Lee, Shashitha Gavini, Krishna Nagendran

Published: 2018-10-01

Everything You Need To Know

1

What cardiovascular risks are associated with long-term steroid use, and why is ventricular septal rupture (VSR) a concern?

Long-term use of corticosteroids can lead to several cardiovascular complications, one of the most severe being ventricular septal rupture (VSR). While common side effects like weight gain and mood changes are well-known, the risk of VSR, where a tear occurs in the heart's ventricular wall, is often overlooked. This condition can reduce the heart's efficiency and lead to heart failure. Although VSR is frequently associated with heart attacks, this case highlights that it can also arise from chronic steroid use, emphasizing the need for vigilance.

2

What is ventricular septal rupture (VSR), and how does it impact the heart's function?

Ventricular septal rupture (VSR) is a rare but critical condition where a tear develops in the septum separating the heart's ventricles. This tear allows blood to flow abnormally between the ventricles. The irregular flow compromises the heart's ability to pump blood effectively, potentially leading to heart failure. While VSR is commonly linked to myocardial infarction, the presented case illustrates it can also be a consequence of long-term steroid use, even in individuals without significant coronary artery disease.

3

What were the initial symptoms and findings that led to the diagnosis of ventricular septal rupture (VSR) in the patient described?

In the case presented, the patient initially presented with acute central chest pain radiating to her back, accompanied by nausea, vomiting, and shortness of breath. Despite these severe symptoms, her initial vital signs and physical examination were relatively normal. However, a key finding was a significantly elevated troponin level, a marker indicating heart damage. Subsequent diagnostic tests, including an electrocardiogram and coronary angiogram, revealed a large apical ventricular septal defect (VSD). An echocardiogram further detailed the extent of the damage, showing reduced ejection fraction and other abnormalities.

4

What steps can individuals taking corticosteroids long-term take to protect their heart health and minimize cardiovascular risks?

To safeguard your heart health while undergoing long-term treatment with corticosteroids, regular check-ups with a healthcare provider are crucial. These check-ups should include monitoring of blood pressure, cholesterol levels, and blood sugar. It's important to promptly discuss any new or worsening symptoms, such as chest pain, shortness of breath, or swelling. By remaining vigilant and collaborating closely with your healthcare team, you can minimize the risks associated with long-term steroid use and maintain cardiovascular well-being. Monitoring ejection fraction via echocardiograms is also important.

5

How does focal segmental glomerulosclerosis and subsequent kidney transplant relate to the cardiovascular complications observed with long-term steroid use?

Focal segmental glomerulosclerosis, present in the patient in the case study, is a kidney disease characterized by scarring in specific sections of the glomeruli, which are the filtering units of the kidneys. The disease progression can lead to kidney failure, often necessitating treatments such as kidney transplantation. Following a kidney transplant, immunosuppressive therapy, including steroids, is commonly prescribed to prevent rejection of the new organ. However, the long-term use of these immunosuppressants, as demonstrated in the case, carries potential cardiovascular risks, underscoring the importance of careful management and monitoring in transplant recipients.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.